Brand liraglutide
Sold by Aspire Health · Injection · device not recorded · every brand liraglutide record
The program identifies an injection, but the delivery device has not been established.
Price
No comparable monthly price verified at this reading. See dated notes for any advertised starting figures.
We earn nothing from this link. It opens Aspire Health's website without a paid referral.
History
Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.
Sourcing and terms
| Pharmacy | Strive Pharmacy / Boudreaux’s New Drug Store / Rush Pharmacy (publicly listed network; individual assignment unconfirmed) |
|---|---|
| States | Not disclosed |
| Prescriber | Both |
| Cancellation | Cancel care by emailing info@aspirehealth.care; cancellation takes effect at the end of the paid billing cycle, without partial-period refunds except as required by law. Consultation services are generally nonrefundable after clinical review, including denial of a requested treatment. The medication-ordering FAQ makes compounded charges nonrefundable once the prescription is sent to the pharmacy, while general terms describe final medication sales after shipment, with stated error exceptions. Cancel auto-refills before renewal or switch to manual refills. https://aspirehealth.care/faq/ |
| Membership | Required. $49 every 28 days. The FAQ explicitly requires $49 every 28 days for Weight Management, starting at enrollment, separately from medication. The main page calls it $49 Monthly Medical Care; its generic monthly wording is not used to convert the specific 28-day cycle into a calendar month. https://aspirehealth.care/faq/ https://aspirehealth.care/weight-loss/ |
| Consult fee | None. “The actual main weight-management page explicitly advertises a free new-patient consultation. Ongoing medical care and medication are separately charged; this does not claim all later services are free.” |
Recorded from aspirehealth.care. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.
Notes
- 1. October 2026 — The current public catalog offers Saxenda with a Schedule Consultation path and describes daily injection. Its medication price varies by insurance and no numerical medication price is published. Manufacturer primary prescribing information identifies liraglutide and subcutaneous injection; no specific device is inferred from provider imagery. https://aspirehealth.care/weight-loss-medications/ https://www.novo-pi.com/saxenda.pdf
- 2. October 2026 — Required care is $49 every 28 days, separately from medication. The current FAQ replaces the older $75/month figure. The public pharmacy list names Strive Pharmacy, Boudreaux’s New Drug Store and Rush Pharmacy (Florida and Texas locations); it does not establish which will fill a particular prescription. The fully loaded service map identifies licensed versus coming-soon states by color. A conservative affirmative subset of 31 clearly blue states is recorded; small ambiguous labels are not asserted. https://aspirehealth.care/faq/ https://aspirehealth.care/service-areas/
- 3. October 2026 — The main weight-loss page explicitly advertises a free new-patient consultation and $49 Monthly Medical Care, while the FAQ states $49 every 28 days. The exact FAQ cycle is retained; a 28-day cycle is not a calendar month. General legal language about consultation fees does not override the explicit free initial consultation offer. https://aspirehealth.care/weight-loss/ https://aspirehealth.care/faq/
- 4. October 2026 — The fully loaded public map marks these 31 clearly identifiable states blue under its Currently Licensed legend: Alaska, Arizona, Colorado, Florida, Hawaii, Idaho, Illinois, Iowa, Kansas, Kentucky, Louisiana, Maine, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Mexico, New York, North Dakota, Oklahoma, South Dakota, Utah, Vermont, Virginia, Washington, Wisconsin, Wyoming. This is a conservative licensure subset, not an exhaustive roster or confirmation that this medication is available in each state. Tiny Delaware, Maryland and District of Columbia markings were not classified. Drug, provider and pharmacy restrictions still apply; full program coverage is not established. https://aspirehealth.care/service-areas/
8 further notes concern other Aspire Health programs and sit on the provider record.
Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.